chr17-61400235-G-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 8P and 1B. PP5_Very_StrongBS2_Supporting
The NM_005994.4(TBX2):c.59G>A(p.Arg20Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000051 in 1,215,720 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000061 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000050 ( 0 hom. )
Consequence
TBX2
NM_005994.4 missense
NM_005994.4 missense
Scores
2
11
6
Clinical Significance
Conservation
PhyloP100: 6.03
Genes affected
TBX2 (HGNC:11597): (T-box transcription factor 2) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product is the human homolog of mouse Tbx2, and shares strong sequence similarity with Drosophila omb protein. Expression studies indicate that this gene may have a potential role in tumorigenesis as an immortalizing agent. Transcript heterogeneity due to alternative polyadenylation has been noted for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PP5
Variant 17-61400235-G-A is Pathogenic according to our data. Variant chr17-61400235-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 522826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 9 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBX2 | NM_005994.4 | c.59G>A | p.Arg20Gln | missense_variant | 1/7 | ENST00000240328.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBX2 | ENST00000240328.4 | c.59G>A | p.Arg20Gln | missense_variant | 1/7 | 1 | NM_005994.4 | P1 | |
ENST00000585765.1 | n.9C>T | non_coding_transcript_exon_variant | 1/4 | 5 | |||||
TBX2 | ENST00000419047.5 | c.59G>A | p.Arg20Gln | missense_variant, NMD_transcript_variant | 1/7 | 1 | |||
TBX2-AS1 | ENST00000592009.1 | n.41-6488C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000614 AC: 9AN: 146628Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
9
AN:
146628
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000496 AC: 53AN: 1069092Hom.: 0 Cov.: 30 AF XY: 0.0000493 AC XY: 26AN XY: 527916
GnomAD4 exome
AF:
AC:
53
AN:
1069092
Hom.:
Cov.:
30
AF XY:
AC XY:
26
AN XY:
527916
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000614 AC: 9AN: 146628Hom.: 0 Cov.: 32 AF XY: 0.0000421 AC XY: 3AN XY: 71312
GnomAD4 genome
AF:
AC:
9
AN:
146628
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
71312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Vertebral anomalies and variable endocrine and T-cell dysfunction Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 05, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 06, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
TBX2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Undiagnosed Diseases Network, NIH | Feb 24, 2016 | This family has been reported in PMID: 29726930 (family 1). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Loss of methylation at R20 (P = 0.0306);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at